Purespring Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Purespring Therapeutics's estimated annual revenue is currently $10.5M per year.
- Purespring Therapeutics's estimated revenue per employee is $155,000
- Purespring Therapeutics's total funding is $165M.
Employee Data
- Purespring Therapeutics has 68 Employees.
- Purespring Therapeutics grew their employee count by 11% last year.
Purespring Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO at Purespring Therapeitics | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief People Officer | Reveal Email/Phone |
4 | Co-founder & Chief Scientific Advisor | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Senior Director Clinical Operations | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Quality Assurance Manager | Reveal Email/Phone |
9 | Financial Planning and Analysis Manager | Reveal Email/Phone |
10 | Scientist | Reveal Email/Phone |
Purespring Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Purespring Therapeutics?
$165M
Total Funding
68
Number of Employees
$10.5M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Purespring Therapeutics News
2022-04-20 - Forcefield Therapeutics Launched With 'Gamechanger' Goal ...
Some investors are shying away from early-stage gene therapy companies, but Richard Francis, CEO of kidney disease specialist Purespring, told...
2022-04-19 - Syncona-backed biotech launches in bid to shield heart cells ...
... Francis told Endpoints News that he got involved with Forcefield since he was CEO of another Syncona company, Purespring Therapeutics.
2022-03-22 - Purespring Positive About Prospects Despite Burst Biotech ...
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders ... Interview: recently appointed CEO Richard Francis will apply his...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.9M | 68 | 3% | N/A |
#2 | $9.5M | 68 | 13% | N/A |
#3 | $12.5M | 68 | 24% | N/A |
#4 | $15.4M | 68 | 6% | N/A |
#5 | $12.9M | 68 | 3% | N/A |